Dermal Filler - Medical Devices Pipeline Assessment, 2017

  • ID: 4315777
  • Report
  • 128 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Aeon Astron Corporation
  • BioPolymer GmbH & Co. KG
  • EternoGen, LLC
  • Juvenis Ltd.
  • Moma Therapeutics, Inc.
  • Sekisui Medical Co Ltd
  • MORE
Dermal Filler - Medical Devices Pipeline Assessment, 2017

Summary

The analyst's Medical Devices sector report, “Dermal Filler - Medical Devices Pipeline Assessment, 2017" provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Dermal Filler under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dermal Filler under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aeon Astron Corporation
  • BioPolymer GmbH & Co. KG
  • EternoGen, LLC
  • Juvenis Ltd.
  • Moma Therapeutics, Inc.
  • Sekisui Medical Co Ltd
  • MORE
1 Table of Contents
2 Introduction
2.1 Dermal Filler Overview
3 Products under Development
3.1 Dermal Filler - Pipeline Products by Stage of Development
3.2 Dermal Filler - Pipeline Products by Territory
3.3 Dermal Filler - Pipeline Products by Regulatory Path
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date
3.5 Dermal Filler - Ongoing Clinical Trials
4 Dermal Filler - Pipeline Products under Development by Companies
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development
4.2 Dermal Filler - Pipeline Products by Stage of Development
5 Dermal Filler Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allergan Inc Company Overview
5.2.1 Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Almirall Ltd Company Overview
5.3.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Anika Therapeutics Inc Company Overview
5.4.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 BioPolymer GmbH & Co. KG Company Overview
5.5.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bioxis Pharmaceuticals Company Overview
5.6.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cytophil, Inc. Company Overview
5.7.1 Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Dermele Skin Care, LLC Company Overview
5.8.1 Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 EternoGen, LLC Company Overview
5.9.1 EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 FibroGen Inc Company Overview
5.10.1 FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Galderma SA Company Overview
5.11.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview
5.12 Innovia LLC Company Overview
5.12.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Juvenis Ltd. Company Overview
5.13.1 Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Khorionyx SA Company Overview
5.14.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 L&C Bio Company Overview
5.15.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview
5.16 Mentor Worldwide LLC Company Overview
5.16.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Moma Therapeutics, Inc. Company Overview
5.17.1 Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Mosaic Medical Technologies, Inc Company Overview
5.18.1 Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Oligo Medic, Inc. Company Overview
5.19.1 Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.20 ORGEV Laboratories Company Overview
5.20.1 ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview
5.21 PetVivo Holdings Inc Company Overview
5.21.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Sekisui Medical Co Ltd Company Overview
5.22.1 Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.23.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 Shin Poong PharmCo Ltd Company Overview
5.24.1 Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sinclair Pharma PLC Company Overview
5.25.1 Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview
5.26 Sofregen Medical Inc Company Overview
5.26.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 TEI Biosciences Inc Company Overview
5.27.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 University of California Santa Barbara Company Overview
5.28.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
6 Dermal Filler- Recent Developments
6.1 Jun 01, 2017: Suneva Medical Celebrates 10 Years of Steady Growth with Flagship Brand, Bellafill
6.2 May 09, 2017: FibroGen Reports First Quarter 2017 Financial Results
6.3 May 09, 2017: Oligo Medic Appoints Jerett Creed As CEO
6.4 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report
6.5 May 03, 2017: Anika Reports First Quarter 2017 Financial Results
6.6 Apr 24, 2017: Juvéderm Vollure XC Dermal Filler -- Long Lasting FDA-Approved Treatment for Diminishing Nasolabial Folds Now Available at Contour Dermatology & Cosmetic Surgery Center
6.7 Apr 06, 2017: Galderma Presents Results From Phase 4 Clinical Study of Restylane Refyne at the 15th Aesthetic & Anti-aging Medicine Annual World Congress
6.8 Apr 06, 2017: Galderma Presents Results From Phase 4 Clinical Study of Restylane Defyne at the 15th Aesthetic & Anti-aging Medicine Annual World Congress
6.9 Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America
6.10 Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016
6.11 Mar 20, 2017: JUVEDERM VOLLURE XC Approved By U.S. FDA For Correction Of Facial Wrinkles And Folds In Adults Over The Age Of 21
6.12 Mar 01, 2017: FibroGen Reports Fiscal 2016 Financial Results
6.13 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
6.14 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
6.15 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results
6.16 Feb 09, 2017: Smith & Nephew: Directorate Change
6.17 Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany
6.18 Jan 27, 2017: Allergan Launches Juvederm Volite - an Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months
6.19 Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update
6.20 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew
6.21 Dec 20, 2016: Appointment of Nestle Skin Health CEO ad interim
6.22 Dec 12, 2016: Galderma Announces FDA Approval of Restylane Refyne Dermal Filler for Treatment of “Laugh Lines”
6.23 Dec 12, 2016: Galderma Announces FDA Approval of Restylane Defyne Dermal Filler for Treatment of “Laugh Lines”
6.24 Nov 30, 2016: Graham Baker appointed Chief Financial Officer
6.25 Nov 21, 2016: Merz Continues Its Growth in Aesthetics and Neurotoxins
6.26 Nov 15, 2016: BTG: Interim results
6.27 Nov 08, 2016: FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update
6.28 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report
6.29 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
6.30 Oct 19, 2016: Facial Aesthetics First in Denver to Offer New Treatment to Help Patients Achieve “Goldilocks Lips”
6.31 Oct 18, 2016: JUVEDERM VOLBELLA XC Now Available To Doctors And Patients In The U.S.
6.32 Oct 10, 2016: Aesthetics Industry Veteran Pat Altavilla Joins Suneva Medical As Vice President Of Marketing
6.33 Oct 06, 2016: BTG: close period update
6.34 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy
6.35 Sep 23, 2016: Biologica Technologies launches Allofill injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons
6.36 Sep 21, 2016: Sinclair Pharma: Second Interim Statement (Jan-Jun 2016)
6.37 Sep 01, 2016: Sinclair Pharma: Restructuring programme and Board change
6.38 Aug 08, 2016: FibroGen Reports Financial Results for the Second Quarter of 2016
6.39 Aug 04, 2016: Suneva Appoints Preston Romm To Chief Executive Officer And Fortifies Board Of Directors With Industry Leaders
6.40 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results
6.41 Jul 27, 2016: BTG Announces Appointment of Non-executive Director
6.42 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results
6.43 Jul 18, 2016: Trading update and notification of board changes £17.2m revenue in 1H calendar 2016
6.44 Jul 14, 2016: BTG: Annual General Meeting
6.45 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017
6.46 Jun 16, 2016: Preston Romm Joins Suneva Medical As Chief Operating Officer
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Dermal Filler - Pipeline Products by Stage of Development
Table 2: Dermal Filler - Pipeline Products by Territory
Table 3: Dermal Filler - Pipeline Products by Regulatory Path
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Table 5: Dermal Filler - Ongoing Clinical Trials
Table 6: Dermal Filler Companies - Pipeline Products by Stage of Development
Table 7: Dermal Filler - Pipeline Products by Stage of Development
Table 8: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: BioDermal Filler - Product Status
Table 10: BioDermal Filler - Product Description
Table 11: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: JUVEDERM Volbella - Product Status
Table 13: JUVEDERM Volbella - Product Description
Table 14: Juvederm Vollure XC - Product Status
Table 15: Juvederm Vollure XC - Product Description
Table 16: Juvederm VOLUMA XC - Product Status
Table 17: Juvederm VOLUMA XC - Product Description
Table 18: Allergan Inc - Ongoing Clinical Trials Overview
Table 19: Juvederm VOLUMA XC - A Multicenter, Single-blind, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of Juvederm VOLUMA XC Injectable Gel for Correction of Temple Hollowing
Table 20: Juvederm VOLUMA XC - Clinical Study of Neuramis Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume
Table 21: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin
Table 22: Juvederm Vollure XC - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults
Table 23: Juvederm Vollure XC - Prospective Open Label Study to Evaluate the Effectiveness of Juvederm VOLIFT with Lidocaine for Treatment of Dynamic Radial Cheek Line Skin Depressions: BEAM
Table 24: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Hyaluronic Acid Facial Filler - Product Status
Table 26: Hyaluronic Acid Facial Filler - Product Description
Table 27: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Next Generation ELEVESS Dermal Filler - Product Status
Table 29: Next Generation ELEVESS Dermal Filler - Product Description
Table 30: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Matridex - Product Status
Table 32: Matridex - Product Description
Table 33: Matridur - Product Status
Table 34: Matridur - Product Description
Table 35: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Cytosial - Product Status
Table 37: Cytosial - Product Description
Table 38: Cytosmile - Product Status
Table 39: Cytosmile - Product Description
Table 40: Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status
Table 42: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description
Table 43: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Gold Nanoparticle Dermal Filler - Product Status
Table 45: Gold Nanoparticle Dermal Filler - Product Description
Table 46: EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Collagen Scaffold - Aesthetic Procedures - Product Status
Table 48: Collagen Scaffold - Aesthetic Procedures - Product Description
Table 49: FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: FG-5030 - Product Status
Table 51: FG-5030 - Product Description
Table 52: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Restylane Lidocaine - Product Status
Table 54: Restylane Lidocaine - Product Description
Table 55: Restylane Lyft - Hand Rejuvenation - Product Status
Table 56: Restylane Lyft - Hand Rejuvenation - Product Description
Table 57: Restylane Perlane - Product Status
Table 58: Restylane Perlane - Product Description
Table 59: Restylane Skinboosters Vital - Product Status
Table 60: Restylane Skinboosters Vital - Product Description
Table 61: Galderma SA - Ongoing Clinical Trials Overview
Table 62: Restylane Perlane - A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency
Table 63: Restylane Perlane - A Randomized, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate with Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane
Table 64: Restylane Perlane - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
Table 65: Restylane Lidocaine - A Multicenter, Active-controlled, Randomized, Evaluator and Subject Blinded, Split-face, Comparative, Non-inferiority and Confirmatory Clinical Study of the Efficacy and Safety Between YYD701-2 and Restylane Perlane Lidocaine for Temporary Correction of Moderate to Severe Nasolabial Folds
Table 66: Restylane Lidocaine - A Randomized, Evaluator-blind Comparative Study to Evaluate Performance and Safety of Restylane Lidocaine and No-treatment Control for Treatment of Depressed Facial Acne Scars
Table 67: Restylane Lidocaine - A Randomized, Multi-center, Subject and Evaluator-blinded Study Comparing Pain and Safety Profile Associated with Correction of Moderate to Severe Nasolabial Folds Using Restylane with and without Addition of 0.3% Lidocaine Hydrochloride
Table 68: Restylane Lidocaine - A Randomized, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate with Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane
Table 69: Restylane Lidocaine - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
Table 70: Restylane Skinboosters Vital - A Randomized, Multi-center, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects
Table 71: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Wrinkle Filler - Product Status
Table 73: Wrinkle Filler - Product Description
Table 74: Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Tenergel - Product Status
Table 76: Tenergel - Product Description
Table 77: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Autologous Globin Dermal Filler - Product Status
Table 79: Autologous Globin Dermal Filler - Product Description
Table 80: L&C Bio Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Micronized Acellular Dermal Filler - Product Status
Table 82: Micronized Acellular Dermal Filler - Product Description
Table 83: Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Prevelle Shape - Product Status
Table 85: Prevelle Shape - Product Description
Table 86: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Restogel-131 - Product Status
Table 88: Restogel-131 - Product Description
Table 89: Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Dermal Filler - Product Status
Table 91: Dermal Filler - Product Description
Table 92: Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 93: AntaRep - Product Status
Table 94: AntaRep - Product Description
Table 95: ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Macdermol 18 - Product Status
Table 97: Macdermol 18 - Product Description
Table 98: Macdermol 21 - Product Status
Table 99: Macdermol 21 - Product Description
Table 100: Macdermol 24 - Product Status
Table 101: Macdermol 24 - Product Description
Table 102: Macdermol 30 - Product Status
Table 103: Macdermol 30 - Product Description
Table 104: Macdermol Bio Lift - Product Status
Table 105: Macdermol Bio Lift - Product Description
Table 106: Macdermol Bio Revitalization - Product Status
Table 107: Macdermol Bio Revitalization - Product Description
Table 108: Macdermol Hydro - Product Status
Table 109: Macdermol Hydro - Product Description
Table 110: Macdermol Lips - Product Status
Table 111: Macdermol Lips - Product Description
Table 112: MacDermol R - Product Status
Table 113: MacDermol R - Product Description
Table 114: MacDermol S - Product Status
Table 115: MacDermol S - Product Description
Table 116: Macdermol Volume - Product Status
Table 117: Macdermol Volume - Product Description
Table 118: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Dermal Filler - Product Status
Table 120: Dermal Filler - Product Description
Table 121: Dermal Filler - Lip - Product Status
Table 122: Dermal Filler - Lip - Product Description
Table 123: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 124: NADGL - Product Status
Table 125: NADGL - Product Description
Table 126: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 127: QST Gel - Product Status
Table 128: QST Gel - Product Description
Table 129: Third Generation Matrifill - Product Status
Table 130: Third Generation Matrifill - Product Description
Table 131: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 132: Dermal Filler - Product Status
Table 133: Dermal Filler - Product Description
Table 134: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Atlean - Product Status
Table 136: Atlean - Product Description
Table 137: Ellanse Hands-M - Product Status
Table 138: Ellanse Hands-M - Product Description
Table 139: Ellanse Hands-S - Product Status
Table 140: Ellanse Hands-S - Product Description
Table 141: Ellansé Lidocaine - Product Status
Table 142: Ellansé Lidocaine - Product Description
Table 143: Ellansé-E - Product Status
Table 144: Ellansé-E - Product Description
Table 145: Ellansé-L - Product Status
Table 146: Ellansé-L - Product Description
Table 147: Ellansé-M - Product Status
Table 148: Ellansé-M - Product Description
Table 149: Ellansé-S - Product Status
Table 150: Ellansé-S - Product Description
Table 151: Perfectha G - Product Status
Table 152: Perfectha G - Product Description
Table 153: Perfectha Lidocaine - Product Status
Table 154: Perfectha Lidocaine - Product Description
Table 155: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Silk Protein - Tissue/Dermal Filler - Product Status
Table 157: Silk Protein - Tissue/Dermal Filler - Product Description
Table 158: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Injectable Dermal Filler - Product Status
Table 160: Injectable Dermal Filler - Product Description
Table 161: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Table 162: Needle Free Injector - Product Status
Table 163: Needle Free Injector - Product Description
Table 164: Glossary

List of Figures
Figure 1: Dermal Filler - Pipeline Products by Stage of Development
Figure 2: Dermal Filler - Pipeline Products by Territory
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Figure 5: Dermal Filler - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aeon Astron Corporation
  • Allergan Inc
  • Almirall Ltd
  • Anika Therapeutics Inc
  • BioPolymer GmbH & Co. KG
  • Bioxis Pharmaceuticals
  • Cytophil, Inc.
  • Dermele Skin Care, LLC
  • EternoGen, LLC
  • FibroGen Inc
  • Galderma SA
  • Innovia LLC
  • Juvenis Ltd.
  • Khorionyx SA
  • L&C Bio
  • Mentor Worldwide LLC
  • Moma Therapeutics, Inc.
  • Mosaic Medical Technologies, Inc
  • Oligo Medic, Inc.
  • ORGEV Laboratories
  • PetVivo Holdings Inc
  • Sekisui Medical Co Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Shin Poong PharmCo Ltd
  • Sinclair Pharma PLC
  • Sofregen Medical Inc
  • TEI Biosciences Inc
  • University of California Santa Barbara
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll